Long term survival in a patient with variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulphate

scientific article published on 21 February 2007

Long term survival in a patient with variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulphate is …
instance of (P31):
case reportQ2782326
scholarly articleQ13442814

External links are
P356DOI10.1136/JNNP.2006.104505
P932PMC publication ID2117700
P698PubMed publication ID17314188
P5875ResearchGate publication ID6492013

P2093author name stringParry A
Stacey R
Baker I
Wimalaratna S
P2860cites workUnsuccessful intraventricular pentosan polysulphate treatment of variant Creutzfeldt-Jakob diseaseQ34511219
Treatment of transmissible spongiform encephalopathy by intraventricular drug infusion in animal modelsQ37730189
Cerebroventricular infusion of pentosan polysulphate in human variant Creutzfeldt-Jakob disease.Q46501596
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectpatientQ181600
Creutzfeldt-Jakob diseaseQ49989
P304page(s)733-734
P577publication date2007-02-21
P1433published inJournal of Neurology, Neurosurgery and PsychiatryQ1599804
P1476titleLong term survival in a patient with variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulphate
P478volume78

Reverse relations

cites work (P2860)
Q33957528Diphenylpyrazole-derived compounds increase survival time of mice after prion infection.
Q33680310Glycosaminoglycan sulphation affects the seeded misfolding of a mutant prion protein
Q33613234Heparin binding confers prion stability and impairs its aggregation
Q39005891Insights from Therapeutic Studies for PrP Prion Disease
Q40078261Orally administered amyloidophilic compound is effective in prolonging the incubation periods of animals cerebrally infected with prion diseases in a prion strain-dependent manner
Q28551264Pentosan Polysulfate: Oral Versus Subcutaneous Injection in Mucopolysaccharidosis Type I Dogs
Q33956775Postmortem findings in a case of variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulfate
Q26741258Prion diseases: immunotargets and therapy
Q35832931Rapidly progressive dementias and the treatment of human prion diseases
Q39236820Sulfated glycosaminoglycans in protein aggregation diseases
Q36743340The variant Creutzfeldt-Jakob Disease: Risk, uncertainty or safety in the use of blood and blood derivatives?
Q36901944Therapeutic approaches for prion disorders
Q37199225Therapies for human prion diseases
Q37080697Toxic effects of intracerebral PrP antibody administration during the course of BSE infection in mice
Q34453109Variant CJD. 18 years of research and surveillance

Search more.